SAB Biotherapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SABS and other ETFs, options, and stocks.About SABS
SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company, which engages in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. The firm produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases.
SABS Key Statistics
Stock Snapshot
With a market cap of 190.05M, SAB Biotherapeutics(SABS) trades at $3.70. The stock has a price-to-earnings ratio of -1.38.
On 2026-03-19, SAB Biotherapeutics(SABS) shares started trading at $4.00, with intraday highs of — and lows of —.
Trading volume for SAB Biotherapeutics(SABS) stock has reached 0, versus its average volume of 1.21M.
The stock's 52-week range extends from a low of $1.00 to a high of $6.60.
The stock's 52-week range extends from a low of $1.00 to a high of $6.60.
Analyst ratings
100%
of 7 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.